MR

Manoj Ramaniklal Vora

Active Director Director DIN 02352497
DIN 02352497 First appointment Oct 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Oct 2008
Shareholding value •••• Premium profile

About Manoj Ramaniklal Vora

Data last updated:

Manoj Ramaniklal Vora is a Director at Alvita Pharma Private Limited (since 2010), Director at Novagen Healthcare Private Limited (since 2014) and Director at Alvita Foundation (since 2021). The companies operate in Pharma and Service. The 3 current companies with reported revenue have a combined latest revenue of ₹166 Cr; the largest is Alvita Pharma Private Limited at ₹120 Cr (FY 2024). Earlier, Manoj Ramaniklal Vora was a Partner at Aumgen Pharma Llp (2019–2023) and Additional Director at Sava Healthcare Limited (2008–2010) and 1 more.

DIN 02352497
Primary Designation Director
Industry Pharma
First Appointment 25 Oct 2008
Oldest Company Age 16 yrs
Largest company Alvita Pharma Private Limited · ₹120 Cr (FY 2024)
Combined revenue ₹166 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alvita Pharma Private Limited U24230GJ2010PTC059305
Director14 Jul 20102010₹120 Cr (FY 2024)Active
Novagen Healthcare Private Limited U74120GJ2014PTC078747
Director14 Feb 20142014₹45.81 Cr (FY 2025)Active
Alvita Foundation U93098MH2021NPL358273
Director05 Apr 20212021₹2.1 Lakh (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner25 Mar 20192017Active
Sava Healthcare Limited U24231GJ1989PLC011921
Additional Director25 Oct 20081989₹219 Cr (FY 2022)Amalgamated
Aztec Pharma Private Limited U24230GJ2011PTC063594
Director11 Jan 20112011₹6.65 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Alvita Pharma Private Limited
Novagen Healthcare Private Limited
Alvita Foundation
Aumgen Pharma Llp
Premium access

Shareholding and investment profile for Manoj Ramaniklal Vora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manoj Ramaniklal Vora

Manoj Ramaniklal Vora currently holds 3 directorships: Alvita Pharma Private Limited (Director, since 14 Jul 2010, revenue ₹120 Cr (FY 2024)); Novagen Healthcare Private Limited (Director, since 14 Feb 2014, revenue ₹45.81 Cr (FY 2025)); Alvita Foundation (Director, since 05 Apr 2021, revenue ₹2.1 Lakh (FY 2023)).

Manoj Ramaniklal Vora was first appointed on 25 Oct 2008 as Additional Director at Sava Healthcare Limited. The most recent appointment on record is 05 Apr 2021 at Alvita Foundation.

The 3 current companies of Manoj Ramaniklal Vora that report revenue have a combined latest revenue of ₹166 Cr: Alvita Pharma Private Limited ₹120 Cr (FY 2024); Novagen Healthcare Private Limited ₹45.81 Cr (FY 2025); Alvita Foundation ₹2.1 Lakh (FY 2023).

Manoj Ramaniklal Vora held 3 earlier board appointments: Aumgen Pharma Llp (Partner, 25 Mar 2019 to 07 Aug 2023); Sava Healthcare Limited (Additional Director, 25 Oct 2008 to 01 Jun 2010); Aztec Pharma Private Limited (Director, 11 Jan 2011 to 22 Dec 2014).

The current boards of Manoj Ramaniklal Vora's companies include Sajan Parmeswaran Unnithan (Alvita Pharma Private Limited), Surendra Kumar Lohia (Alvita Pharma Private Limited), Manoj Balakrishna Pillai (Novagen Healthcare Private Limited), Vasant Nagappa Salian (Novagen Healthcare Private Limited), Jatin Ramniklal Vora (Alvita Foundation), Sangeetha Manoj Vora (Alvita Foundation).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available